ARCHIVES

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

This article is from The Cancer Letter archive.

Vol. 26 No. 29 | July 21, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013